Published: 2019-03-06 08:07:10 CET
Olainfarm
Other information disclosed according to the rules of the Exchange

Recording of the Fourth Quarter 2018 Investor Conference Webinar

On March 5 JSC Olainfarm organized its Investor Conference - Online Webinar. During the webinar the Advisor to the Board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of fourth quarter and 12 months of 2018 and informed about other recent activities within the company.

The recorded webinar is available online: https://bit.ly/2C7XcdY, and the presentation, demonstrated during the webinar, is available in the previously published announcement.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with over 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
         
Inga Krūkle
Member of the Board JSC Olainfarm
Ph.: +371 28698449
inga.krukle@olainfarm.com